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Preeclampsia is a pregnancy-specific hypertensive disorder that affects 2% to 8% of all pregnancies.1 Women with pre-
vious preeclampsia have a 2-fold higher risk of cardiovascular 
morbidity and mortality later in life.2 Additional complications 
to preeclampsia such as miscarriage, preterm birth, and intra-
uterine growth restriction synergistically increase the associa-
tion to later cardiovascular disease (CVD).3–5
Preeclampsia causation is complex and multi-factorial. 
Preeclampsia and CVD share many common risk factors, such 
as hypercholesterolemia, obesity, increasing age, and diabetes 
mellitus.6,7 Compared with women without preeclampsia, the 
cardiovascular function in women who later develop pree-
clampsia has been found to be different before pregnancy or 
altered in early pregnancy. In these studies, women that later 
developed preeclampsia had a higher peripheral vascular re-
sistance and a lower cardiac output compared with women 
with subsequent normal pregnancies.8,9 It is debated whether 
preeclampsia might be caused by failure of adaptation of the 
cardiovascular system secondary to the increased demand 
from the maternal system and the fetoplacental unit, leading 
to a state of intermittent placental hypoxia and subsequent en-
dothelial dysfunction secondary to hypoxic debris from the 
placenta.8 This maladaptation could reveal an underlying de-
ficiency in the cardiovascular system already present at the 
time of pregnancy, putting these women at higher risk for 
CVD later in life.8 Together, this reinforces the hypothesis of 
preeclampsia as a cardiovascular stress test during pregnancy. 
Because preeclampsia is an adverse pregnancy outcome with 
a heterogenous pathophysiology, this hypothesis could hold 
true for some women but perhaps not for all. Some also argue 
that preeclampsia in itself is an insult to the cardiovascular 
system during pregnancy also in women without predisposi-
tion for CVD and that the insult as such causes the increased 
long-term risks for CVD in these women.10
Women with multi-fetal pregnancies are at about 3 to 
4 times higher risk of preeclampsia,11,12 also when adjusted 
for potential confounders.13 The incidence of preeclampsia 
among women with multi-fetal pregnancies in Scandinavia is 
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between 10% and 18%,12–14 but these pregnancies are often 
excluded from preeclampsia studies.7 It is likely that pree-
clampsia cause in multi-fetal pregnancies differs from other 
preeclampsia subtypes. Multi-fetal pregnancies pose a higher 
load on the cardiovascular system, partly manifested by 
higher cardiac output and lower total vascular resistance.15 
The underlying cause of preeclampsia in women with multi-
fetal pregnancy could be more specific to pregnancy itself (eg, 
higher demand on the cardiovascular system from increased 
syncytiotrophoblast stress from one larger placenta or 2 pla-
centas more rapidly stressed during pregnancy), rather than 
the preexisting cardiovascular risk factors described above. 
Data on placental histopathology from pregnancies compli-
cated by preeclampsia show significantly lower rates of ma-
ternal and fetal vascular lesions in multi-fetal compared with 
singleton pregnancies, supporting the hypothesis of different 
mechanisms behind the disease.16 Multi-fetal pregnancy itself 
is not a risk factor for underlying maternal cardiovascular pa-
thology; data show that women with multi-fetal pregnancies 
without preeclampsia do not experience an increased risk of 
later CVD compared with women with singleton pregnan-
cies without preeclampsia.14 Theoretically, women with pre-
eclampsia in a multi-fetal pregnancy could run a lower risk 
of later CVD compared with women with preeclampsia com-
plicating a singleton pregnancy if preeclampsia in multi-fetal 
pregnancy is the result of the increased demand on the cardi-
ovascular system rather than an underlying disadvantageous 
cardiovascular profile. To the best of our knowledge, there are 
no studies investigating the long-term cardiovascular outcome 
after a multi-fetal pregnancy complicated by preeclampsia.
The aim of this study was to further explore the long-
term effects of preeclampsia by investigating if women with 
multi-fetal pregnancies complicated by preeclampsia have an 
increased risk of CVD compared with women with singleton 
pregnancies without preeclampsia. This would help to person-
alize follow-up and interventions after a pregnancy compli-
cated by preeclampsia.
Methods
The data that support the findings of this study are available from the 
corresponding author on reasonable request.
Data Sources
The study population was derived from the Swedish Medical Birth 
Register (MBR) and was individually linked to other national popula-
tion-based registers held by the National Board of Health and Welfare 
(https://www.socialstyrelsen.se) and Statistics Sweden (https://www.
scb.se), using the person unique identification number assigned to 
each citizen at birth or emigration to Sweden (Figure 1).17 The MBR 
includes >98% of all deliveries in Sweden since 1973. The register 
includes prospectively collected information on demographic data, 
reproductive history, and information from the pregnancy, delivery, 
and neonatal period using standardized prenatal, obstetric, and neo-
natal records.18 Diagnoses classified according to the Swedish version 
of the International Classification of Diseases (ICD) (ICD-8 until 
1986, ICD-9 between 1987 and 1996, and ICD-10 from 1997 and 
onwards) for the mother and the infant at discharge from the delivery 
hospital are further registered.
The Swedish Patient Register was established in 1964 (nation-
wide since 1987) and includes dates of hospital admission and ICD 
codes on in-patients. Since 2001, the register also includes informa-
tion on outpatient visits in specialized health care.19 Further linkage 
to the Swedish Cause of Death Register20 and to the Register of Total 
Population for information on migration to and from Sweden.21 From 
the Education Register and the Income Register, information on dis-
posable household income and the highest achieved level of educa-
tion in the were included (Figure 1).
Study Population
The source population included all women born in Sweden from 
January 1, 1950, until December 31, 1971, with deliveries in the MBR 
from January 1, 1973, to December 31, 2010 (n=2 120 297; Figure 1). 
After exclusions, the study population consisted of 892 425 nullipa-
rous women who were living in Sweden, with singleton or multi-fetal 
pregnancies, without an existing diagnosis of CVD (ischemic heart 
disease, heart failure, or cerebrovascular disease according to ICD 
diagnoses defined in Table S1 in the Data Supplement) at start of fol-
low-up 3 months after birth (Figure 1).
Exposure Variables
The exposure was defined as a combination of maternal diagnosis of 
preeclampsia during the first pregnancy (yes/no) and plurality of the 
pregnancy (ie, singleton or multi-fetal). The key exposure category 
was multi-fetal pregnancies with preeclampsia (motivated by our hy-
pothesis about normal long-term CVD risk in these women; repre-
sented as Box D in Figure 1). The reference category, representing 
women with normal long-term cardiovascular risk, was women with 
a first singleton pregnancy without preeclampsia (Box A in Figure1). 
The other preeclampsia/plurality combinations were also studied, 
to paint a fuller picture of long-term CVD risk of this population. 
Women with preeclampsia complicating a singleton pregnancy (Box 
B, Figure 1) and women with multi-fetal pregnancies without pre-
eclampsia (Box C, Figure 1) were also compared with the referent 
group of singleton pregnancies without preeclampsia. Preeclampsia 
was defined by corresponding ICD-8, -9, or -10 codes of pree-
clampsia and superimposed preeclampsia registered in the MBR (de-
fined in Table S1 in the Data Supplement). Information on singleton 
or multi-fetal pregnancy was retrieved from the delivery record.
Covariates
We sought to control for key covariates that may be associated with 
both preeclampsia in first pregnancy and plurality, as well as long-
term CVD risk. These potential confounders included maternal 
sociodemographic factors and health factors. Given the long study 
period required to track women’s development of CVD over time 
with sufficient statistical power, we included data from many eras 
of data collection. Through the years, variables have been added 
to the MBR, for example, smoking during pregnancy (in 1987), 
body mass index (in 1992), and assisted reproductive technology 
(in 1985). Therefore, some covariates were possible to take into 
account across the whole study period and others only for a re-
stricted time of the study period.
From 1973 and Onwards
Information on date of birth, maternal age at delivery, and gestational 
length at delivery was retrieved from the MBR. Chronic hypertension 
before first birth data was retrieved from the MBR, reported as check-
boxes in the standardized antenatal care record or as ICD codes coded 
during pregnancy (Table S1). The highest level of education for the 
mother was obtained from the Education Register and categorized as 
9 years of schooling or less, 10 to 12 years of schooling, and 13 years 
or more, achieved in 2011 (for all women in the study population).
From 1987 and Onwards
Self-reported information on infertility duration and daily cigarette 
smoking or not in early pregnancy was retrieved from the standard-
ized antenatal record in the MBR. The household’s disposable in-
come in the years of 1990, 1995, 2000, 2005, and 2011 was retrieved 
from the Income Register. The disposable household income for all 
women was categorized into tertiles of the distribution of each of the 
year. The 2 years closest to birth was used for each woman, and the 
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of disposable income in 1995 and in 2000 was used, and the woman 
was categorized according to the highest tertile; for births before 
1995 the disposable income in 1990 and 1995 was used).
From 1995 and Onwards
Body mass index (kg/m2) was collected from the first attendance to 
antenatal care, occurring before 13 weeks of gestation for 90% of 
women in Sweden22 and was divided according to the World Health 
Organization’s classification.23 The standardized antenatal record fur-
ther contains information on assisted reproductive technology and 
concurrent diseases, kidney disease, and systemic lupus erythema-
tosus, collected from check-boxes, diabetes mellitus, collected from 
check-boxes, and ICD codes and categorized as no diabetes mellitus, 
pregestational (type I and II) diabetes mellitus, and gestational dia-
betes mellitus (Table S1).
Outcome Variables
CVD event was defined as diagnosis of, or underlying cause of death 
due to, one of the 3 groups of diagnosis of ischemic heart disease, 
heart failure, or cerebrovascular disease, whichever occurred first in 
the case of multiple morbidities. Chronic hypertension was not part 
of the CVD outcomes since ICD diagnoses in the primary health care 
centers are not available. Diagnoses with corresponding ICD codes 
are defined in Table S1. To minimized capture of false-positive out-
come (eg, due to a code being recorded for diagnostic testing rather 
than confirmed case) diagnosis of CVD was defined as the first of (1) 
one ICD code of CVD in the inpatient register or (2) one ICD code 
of CVD in the outpatient, and within 1 year one ICD code in the 
inpatient register (using the date from the outpatient visit) or (3) 2 
codes in the outpatient register within 1 year (using the date from the 
first visit). Information on death due to CVD was retrieved from ICD 
codes in the cause of death register.
Statistical Methods
Descriptive statistics were presented with mean, medians, SD, and 
frequencies, comparing between our 4 exposure groups defined by 
preeclampsia and plurality, using the Pearson χ2 test for categorical 
data and the Student t test for mean of continuous variables. To max-
imize power and to make use of the full data, we conducted analyses 
in the population of women with deliveries from 1973 to 2010, 1987 
to 2010, and 1995 to 2010.
Data were analyzed using time-to-event methods for the popula-
tion of women giving birth 1973 to 2010 and to control for important 
covariates that only become available later, we also conducted time-
restricted analyses among women giving birth 1987 to 2010. The 
confounders were chosen by a priori knowledge and in addition by 
availability in the registers. Some variables such as body mass index 
were only available from 1995 and are presented in Table S2 to give 
the most detailed picture possible of the study population, but there 
were no time-to-event analyses of the restricted population of deliver-
ies 1995 to 2010 due to small groups.
The event of interest was the first CVD event during follow-up. 
Time at risk was accumulated from entry into the cohort (maternal 
age at 3 months after the first delivery) until CVD event or censoring 
(maternal age at emigration, death from other cause, or last day of 
follow-up, December 31, 2011). Attained age was used as the under-
lying time scale for survival analysis, reflecting that this is the time 
scale that most immediately affects risk of CVD.
The exposure was investigated as a categorical variable (multi-
fetal pregnancy with preeclampsia, singleton pregnancy with pree-
clampsia, multi-fetal pregnancy without preeclampsia, all compared 
with singleton pregnancy without preeclampsia).
To investigate possible associations between the exposure and 
CVD incidence, we used the Kaplan-Meier curves and Cox propor-
tional hazard models, yielding hazard ratios (HR) with 95% CIs. The 
proportional hazard assumption was formally assessed by using the 
Schoenfeld and scaled Schoenfeld residuals. Assumption testing sug-
gested that chronic hypertension before first birth did not satisfy the 
assumption of proportionality.
In the main analysis of women giving birth 1973 until 2010, 
Kaplan-Meier curves were performed for the total population and 
were stratified by age at the end of follow-up (<50 years and 50 
years or older), to explore the risk of right censoring. The Cox pro-
portional hazard models were analyzed unadjusted and adjusted 
for maternal age at delivery (in addition to age as underlying time 
scale), chronic hypertension before first birth, level of education, 
and time period of birth. In the analysis of the restricted study pop-
ulation giving birth from 1987 to 2010, HRs were additionally 
adjusted for tertiles of disposable household income, infertility 
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duration, and daily smoking in early pregnancy. In sensitivity anal-
yses, analyses were conducted stratified by chronic hypertension, 
rather than adjusting for these in the Cox regression to account for 
the possible nonproportionality.
Statistical analyses were performed using the SAS software ver-
sion 9.4. and STATA software version 14.
This study was approved by the Regional Ethical Review Board 
in Stockholm, Sweden (IRB/KI 2012/1325-31/3).
Results
Maternal Characteristics
When comparing women with multi-fetal pregnancies to 
women with singleton pregnancies, women with multi-fetal 
pregnancies were older, had a shorter mean gestational length, 
a larger proportion had higher household disposable income 
and a higher level of education than women with singleton 
pregnancies. The proportion of multi-fetal pregnancies over 
time was higher during the latter years of the study period 
(Tables 1 and 2).
Comparing women without and with preeclampsia within 
plurality (ie, within singleton and within multiples), suggested 
that preeclampsia phenotypes did differ by plurality of the 
first pregnancy. Women with singleton pregnancies and pre-
eclampsia had a shorter duration of pregnancy, a lower level 
of maternal education, a lower household disposable income, 
more often pregestational diabetes mellitus, a longer duration 
of infertility, and more often had infertility treatment than 
women with singleton pregnancies without preeclampsia. In 
contrast, women with preeclampsia complicating a multi-fetal 
pregnancy had a longer duration of pregnancy, a higher ma-
ternal education and less commonly had pregestational dia-
betes mellitus as compared to multi-fetal pregnancies without 
preeclampsia (Tables 1 and 2 and Table S2).
Shared risk factors for preeclampsia in both singleton and 
multi-fetal pregnancies were higher maternal age, higher body 
mass index, and presence of gestational diabetes mellitus. A 
shared protective factor was smoking.
Time to CVD
Duration of follow-up (ie, time from 3 months after giving 
birth to incident CVD or censoring) ranged from 9 months to 
Table 1. Maternal and Pregnancy Characteristics According to Singleton Without and With Preeclampsia and Multi-Fetal Without and With Preeclampsia in First 
Deliveries Among 892 425 births 1973–2010
Maternal and Pregnancy 
Characteristics of First Births
Singleton Pregnancy Multi-Fetal Pregnancy
Without Preeclampsia With Preeclampsia Without Preeclampsia* With Preeclampsia†
1973–2010 N  N  N  N  
N total 892 425 847 567  33 404  9935  1519  
Maternal age at delivery, y
  Mean (SD)  26.6 (5.0)  27.3 (5.3)  29.4 (5.4)  30.3 (5.5)
  Median  25.9  26.6  29.3  30.3
Maternal education, y %
  ≤9 75 421 8.9 2712 8.1 666 6.7 84 5.5
  10–12 422 996 50.1 17 307 52.0 4641 46.9 695 45.8
  >12 346 248 41.0 13 292 39.9 4600 46.4 738 48.7
  Missing 2902  93  28  2  
Chronic hypertension, % 3211 0.4 220 0.7 62 0.6 7 0.5
Gestational length, d
  Mean (SD)  279.8 (13.4)  270.1 (20.6)  253.6 (23.6)  255.9 (17.4)
  Median  282  275  259  259
Preterm birth, %
  < Gestational week 37 46 506 5.5 6713 20.1 4821 48.5 749 49.3
Time period of birth, %
  1973–1978 142 794 16.9 3701 11.1 891 9.0 69 4.5
  1979–1984 171 433 20.2 6110 18.3 1291 13.0 151 9.9
  1985–1990 222 799 26.3 8655 25.9 2047 20.6 270 17.8
  1991–1995 162 083 19.1 7280 21.8 2380 24.0 376 24.8
  1996–2000 87 544 10.3 4623 13.8 1877 18.9 334 22.0
  2001–2005 47 068 5.6 2276 6.8 1121 11.3 230 15.1
  2006–2010 13 846 1.6 759 2.3 328 3.3 89 5.9
*Multi-fetal pregnancy without preeclampsia, including 251 triplets or more.
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38 years and 9 months. The overall median age at the end of 
follow-up was 49.7 years (interquartile range 44.8–55.4) and 
at CVD event, the median age was 48.4 years (interquartile 
range 42.8–53.0). Women with multi-fetal pregnancies were 
older at the time of CVD diagnosis compared with women 
with singleton pregnancies (median 49.7 versus 48.3 years).
In total, 18 415 (2.1%) of the women in the study were 
diagnosed with CVD during the time of follow-up (Tables 3 
and 4). In women with singleton pregnancies, CVD was re-
ported in 17 217 (2.0%) of women without preeclampsia and 
1029 (3.1%) of women with preeclampsia. In women with 
multi-fetal pregnancies, CVD was reported in 145 (1.5%) of 
women without preeclampsia and 24 (1.6%) of women with 
preeclampsia.
Variables associated with long-term risks of CVD were 
preterm birth, chronic hypertension before first birth, lower 
educational level, (Table 3), longer duration of infertility and 
lower household disposable income, smoking (Table 4), obe-
sity, pregestational and gestational diabetes mellitus and sys-
temic lupus erythematosus (Table S4).
Results from the time-to-event analyses for later CVD 
in births 1973 to 2010 are presented in Table 5 and Figure 2. 
When adjusted for maternal age at delivery, chronic hyper-
tension before first birth, level of education and time period 
of birth, women with preeclampsia in a singleton pregnancy 
had 75% higher adjusted HR for CVD compared with women 
with singleton pregnancies without preeclampsia (adjusted 
HR 1.75 [95% CI, 1.64–1.86]). This increased risk was not 
observed among women with multi-fetal pregnancies without 
preeclampsia (adjusted HR 0.94 [95% CI, 0.79–1.10]). The 
hazard of CVD among women with preeclampsia in a multi-
fetal pregnancy was not statistically different from the hazard 
among women without preeclampsia in a singleton pregnancy 
(adjusted HR 1.25 [95% CI, 0.83–1.86]); however, the point 
estimate was further from the null value of 1, and 95% CIs 
were wide.
In analyses of the restricted population giving birth 1987 to 
2010, additional adjustments for household disposable income 
tertile, infertility duration, and smoking in early pregnancy 
were done. The results remained similar with an increased rel-
ative risk among women with singleton pregnancies and pre-
eclampsia but not among women with multi-fetal pregnancies 
without or with preeclampsia (Table 6). Additional analyses 
stratified by chronic hypertension gave similar results (results 
not shown).
To address the different lengths of follow-up, since multi-
fetal pregnancies were more common in later years, we ana-
lyzed women with age at the end of follow-up <50 years and 
>50 years, respectively, and results remained similar (Table 
S5A and S5B and Figure 2B and 2C).
Discussion
Main Findings
In this large Swedish population-based cohort study of pri-
miparous women, our results suggested that the risk of CVD 
after a multi-fetal pregnancy with preeclampsia was not 
increased compared with after a singleton pregnancy without 
preeclampsia.
Interpretation
Preeclampsia phenotypes appear to be different when com-
paring preeclampsia in singleton and multi-fetal pregnancies. 
Pregestational diabetes mellitus, infertility, and lower socio-
economic status are common cardiovascular and metabolic 
risk factors for preeclampsia and CVD; and in our study, these 
were confirmed risk factors for preeclampsia in singleton 
pregnancies. Although they were not associated with pre-
eclampsia in multi-fetal pregnancies. This suggests that the 
Table 2. Additional Maternal and Pregnancy Characteristics According to Singleton Pregnancy Without and With Preeclampsia or Multi-Fetal Pregnancy Without and 
With Preeclampsia in First Deliveries in the Restricted Population of 496 370 Births 1987–2010
Maternal and Pregnancy 
Characteristics of First Births
Singleton Pregnancy Multi-Fetal Pregnancy
Without Preeclampsia With Preeclampsia Without Preeclampsia* With Preeclampsia†
1987–2010 N  N  N  N  
N total=496 370 466 957  21 007  7180  1226  
Disposable annual income around birth, %
  First tertile 96 565 20.9 4652 22.3 922 13.0 188 15.5
  Second tertile 184 807 40.0 8596 41.3 2526 35.7 451 37.2
  Third tertile 180 160 39.0 7572 36.4 3632 51.3 574 47.3
  Missing 5425  187  100  13  
Reported infertility duration, y %
  No 418 751 89.7 18 357 87.4 4692 65.4 800 65.3
  1–2 24 505 5.3 1295 6.2 598 8.3 102 8.3
  3–5 16 294 3.5 873 4.2 1148 16.0 207 16.9
  >5 7407 1.6 482 2.3 742 10.3 117 9.5
Daily smoker at registration 80 162 17.2 2468 11.8 969 13.5 87 7.1
*Multi-fetal pregnancy without preeclampsia, including 223 triplets or more.
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degree to which preeclampsia is an underlying risk profile for 
CVD differs by plurality.
If all phenotypes of preeclampsia had a persistent harmful 
effect on the endothelium, the long-term CVD risk would also 
be present after a multi-fetal pregnancy with preeclampsia. In 
this cohort, women with multi-fetal pregnancies preeclampsia 
did not demonstrate an increased risk of CVD later in life 
compared with women with singleton pregnancies without 
preeclampsia. Furthermore, women with multi-fetal pregnan-
cies without preeclampsia had a similar risk of later CVD as 
women with singleton pregnancies, supported in earlier pub-
lished data.14 This implies that women with multi-fetal preg-
nancies have a similar risk regarding later CVD but when 
complicated by preeclampsia, the increased risk for later CVD 
is not present, supporting a different underlying pathophysi-
ology for preeclampsia in multi-fetal pregnancy. We propose 
that preeclampsia in multi-fetal pregnancies might result from 
increased inflammatory burden as a primary placental finding 
disorder or secondary to placental hypoperfusion as a conse-
quence of the increased burden of multi-fetal pregnancy on 
the maternal cardiovascular system, rather than an underlying 
cardiovascular risk profile, in line with previous published 
concepts.15,24–26
Recent research has emphasized the role of the cardi-
ovascular system in the development of preeclampsia8 and 
emphasized that pregnancy can be seen as a window of op-
portunity to identify future risk of CVD among women devel-
oping preeclampsia.27 This data mostly applies for singleton 
pregnancies and the risk of CVD after a multi-fetal pregnancy 
has not been evaluated.27 The underlying hypothesis of a mal-
adaptation of the cardiovascular system in pregnancy would 
be that the placenta turns hypoxic due to an insufficient de-
livery of oxygen secondary to an affected cardiovascular 
system and harmful molecules such as the antiangiogenic 
factor sFlt-1 (soluble FMS-like tyrosine kinase-1) enter the 
mothers bloodstream from the hypoxic placenta. In addition, 
the angiogenic PlGF (placental growth factor) is secreted in 
reduced amounts. Recent evidence has drawn interest to the 
burden of a larger placenta at term and the risk of late-onset 
preeclampsia in singleton pregnancies.25 The proponents 
of this hypothesis suggest that such placental overcrowding 
is paralleled by increased syncytiotrophoblast stress, an ex-
cessive antiangiogenic state, and ensuing excessive vascular 
Table 3. Maternal and Pregnancy Characteristics According to Later 
Compound Cardiovascular Disease Among 892 425 First Deliveries 1973–2010
Maternal and Pregnancy 






Total 892 425 18 415 2.1
Singleton 880 971 18 246 2.1
  Singleton without preeclampsia 847 567 17 217 2.0
  Singleton with preeclampsia 33 404 1029 3.1
Multi-fetal 11 454 169 1.5
  Multi-fetal without 
preeclampsia
9935 145 1.5
  Multi-fetal with preeclampsia 1519 24 1.6
Maternal age at delivery, y
  <30 679 245 15 615 2.3
  30–34 151 638 2084 1.4
  35–39 52 728 608 1.2
  ≥40 8814 108 1.2
Preterm birth
  ≥Gestational week 37 833 636 16 761 2.0
  <Gestational week 37 58 789 1654 2.8
Maternal education, y
  ≤9 78 883 3191 4.1
  10–12 445 639 10 119 2.3
  >12 364 878 4998 1.4
  Missing 2918 107  
Chronic hypertension
  No 888 925 18 271 2.1
  Yes 3500 144 4.1
Time period of birth
  1973–1978 147 455 6916 4.7
  1979–1984 178 985 5274 3.0
  1985–1990 233 771 3886 1.7
  1991–1995 172 119 1561 0.9
  1996–2000 943 78 566 0.6
  2001–2005 50 695 185 0.4
  2006–2010 15 022 27 0.2
Table 4. Additional Maternal and Pregnancy Characteristics According to Later 
Compound Cardiovascular Disease in the Restricted Population of 496 370 First 
Deliveries 1987–2010
Maternal and Pregnancy 





Total 496 370 4812 1.0
Disposable income
  First tertile 102 327 984 1.0
  Second tertile 196 380 1831 0.9
  Third tertile 191 938 1951 1.0
  Missing 5725 46  
Reported infertility duration, y
  No 442 600 4178 0.9
  1–2 26 500 266 1.0
  3–5 18 522 193 1.0
  >5 8748 175 2.0
Daily smoker at registration
  No 412 684 3226 0.8
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inflammation. Whether the latter occurs due to a primary pla-
cental problem or secondary to maternal hypoperfusion of the 
placenta remains to be determined.25,27–29
Strengths and Limitations
A distinct strength of this study is the nation-wide popula-
tion-based design including women giving birth over several 
decades and a virtually complete follow-up. The large pop-
ulation enabled us to study the rare exposure of multi-fetal 
pregnancy and preeclampsia with the outcome of CVD. The 
high-quality data from several Swedish national registers 
were merged, providing a unique possibility to define a cohort 
without previous diagnoses of CVD and to combine informa-
tion on socioeconomic status, chronic diseases, and pregnancy 
data, with later diagnosis of CVD. Several important con-
founders were possible to consider, although some were not 
available for the whole study period. Analysis on the restricted 
population of births 1987 to 2010 was, therefore, performed 
with similar results.
Although the comprehensiveness of the data, the quality of 
the data is still a concern. Chronic hypertension could unfortu-
nately not be included in our CVD outcomes since we cannot 
assess the ICD diagnosis of chronic hypertension reliably in 
the Patient Register, only including inpatient and outpatient 
diagnosis received in specialized health care and not in health 
centers. Thus, we would greatly underestimate the incidence 
of this diagnosis in our study. To improve the accuracy of the 
CVD diagnosis, one diagnosis in the inpatient, or one in out-
patient and one in inpatient, or 2 diagnoses in the outpatient 
register within a year was required. The CVD diagnoses in 
the in-patient register have previously shown a high validity.19 
Potential nondifferential misclassification of the time to CVD 
event by using the ICD-8 to -10 codes could have been intro-
duced since the outpatient register was not nation-wide until 
1987, the inpatient started in 2001, and multi-fetal pregnancies 
were more common in the latter years. This also implies that 
a larger proportion of multi-fetal pregnancies were followed 
for a shorter period of time. Furthermore, a longer follow-up 
time increases the possibility of developing other risk factors 
for CVD. These concerns were addressed by using maternal 
age as the time scale instead of using the start of follow-up as 
time zero, by adjusting for time period of birth, and for con-
founders as level of education that have an impact on the risk 
of CVD over time. Furthermore, the results persisted in the 
restricted analyses of births 1987 and 2010.
The highest level of education achieved in 2011 was used 
for all women in the study population, irrespective of year of 
delivery. We think that the total attained education is the op-
timal measure for defining maternal education as a proxy of 
socioeconomic status because the intention to attain higher 
education often exists in women before they give birth. With 
this definition, however, women giving birth earlier during the 
study period had the opportunity to attain higher education for 
a longer period than women giving birth closer to the end of 
the study period.
Despite the duration of the study period of >38 years, there 
is a risk of right censoring. The mean age at the end of fol-
low-up was 50 years, and there may be special circumstances 
for women who are affected by CVD in early age compared 
with later. This was addressed by stratified analyses of women 
with age <50, and 50 years and older at the end of follow-up 
were conducted showing similar results, however, analyses 
were potentially hampered by lack of power (Table S5A and 
S5B and Figure 2B and 2C).
Earlier studies have shown a j-shaped relationship be-
tween increasing parity and higher incidence of CVD later 
in life. If women with multi-fetal pregnancies more rarely 
underwent a subsequent pregnancy than women with sin-
gleton pregnancies, the total number of pregnancies among 
these women will be decreased. Given that this study in-
cluded a woman’s first pregnancy, any effect owing to sub-
sequent number of pregnancies would be a mediation effect 
(ie, part of the causal pathway). Therefore, we did not adjust 
Table 5. Hazard Ratios for Later Compound Cardiovascular Disease From 
Maternal Age 3 Months After Delivery Among 892 425 Women With Singleton 
First Deliveries Without and With Preeclampsia and Multi-Fetal First Deliveries 






Singleton without preeclampsia Ref Ref
Singleton with preeclampsia 1.72 (1.61–1.83) 1.75 (1.64–1.86)
Multi-fetal without preeclampsia 0.84 (0.71–0.99) 0.94 (0.79–.10)
Multi-fetal with preeclampsia 1.09 (0.73–1.62) 1.25 (0.83–1.86)
*Adjusted for maternal age at delivery, chronic hypertension before first 
birth, level of education, and time period of birth. Number of observations read 
889 400.
Figure 2. Kaplan-Meier plot for later compound cardiovascular disease. Time is presented as maternal age 3 months after delivery among. Kaplan-Meier 
plot for later compound cardiovascular disease from maternal age 3 months after delivery among 892 425 women with singleton first deliveries without and 
with preeclampsia and multi-fetal first deliveries without and with preeclampsia 1973–2010 (A) and stratified by women with age at the end of follow-up <50 y 
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for number of subsequent pregnancies. Furthermore, par-
ous women without previous preeclampsia could have had 
preeclampsia in a following pregnancy, potentially leading 
to an increased risk of CVD, then diluting the results. The 
risk of preeclampsia among nulliparous women is, however, 
much higher than in parous women, and the vast majority of 
women with preeclampsia in second pregnancy have a recur-
rence of the disease.30
The incidence of preeclampsia increased over the study 
period which is also confirmed in other populations.31 
Agreement between preeclampsia diagnoses in the MBR 
and information in individual medical records were ex-
cellent when ICD-9 codes were used,12 and the increase is 
probably not due to underreporting but rather a true increase 
in the population.
Compared with singleton pregnancies, women with multi-
fetal pregnancies have shorter median gestational length at 
delivery due to increased rates of spontaneous preterm birth 
and iatrogenic preterm birth due to higher incidence of pre-
eclampsia, induction of labor according to practice, or other 
circumstances such as the individual wish of the mother or 
other underlying medical conditions. In Sweden, the majority 
of centers recommend induction of labor at 36 to 38 weeks 
in women with a multi-fetal pregnancy. This incidence cor-
responds to other published literature where numbers reported 
range from 41%32 to 56%.33 Generally, women with multi-fetal 
pregnancies, therefore, have a shorter period to develop pre-
eclampsia than singleton pregnancies have. Preterm birth can 
be considered an effect of preeclampsia in women delivered 
preterm due to preeclampsia. Preterm birth in women without 
preeclampsia may, however, truncate a woman’s time at risk 
for developing preeclampsia (by shortening pregnancy). This 
would result in a reduction of person-time at risk for the ex-
posure of preeclampsia. Preterm birth was not included in the 
adjusted analyses since it predominately was not considered a 
confounding factor.
Perspectives
Women with multi-fetal pregnancies complicated by pree-
clampsia did not show an increased risk of CVD compared 
with women without preeclampsia with singleton pregnan-
cies. These results, and different risk factors for preeclampsia 
between singleton and multi-fetal pregnancies, support the 
hypothesis that, in multi-fetal pregnancies, preeclampsia might 
to a larger extent be a result of increased vascular burden by 
excessive inflammatory factors released from a larger and dys-
functional placenta, rather than an unfavorable cardiovascular 
phenotype in the mother. If so, this has important implications 
for long-term care of women, where women with multi-fetal 
pregnancies complicated by preeclampsia might not be in 
exaggerated risk of cardiovascular risk. It will be important 
for future research to further study downstream risks of both 
gestational hypertension and preeclampsia among multi-fetal 
pregnancies, such as epilepsy and dementia and longer dura-
tion of follow-up for CVDs, including chronic hypertension. 
This research has the potential to increase understanding of 
preeclampsia cause and to more individually and optimally 
tailor the long-term care of women.
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What Is New?
•	Women with multi-fetal pregnancies do not exhibit an increased risk 
of future cardiovascular disease compared with women with singleton 
pregnancies.
•	The underlying pathophysiology in preeclampsia in multi-fetal pregnancy 
is possibly caused by the increased burden of pregnancy rather than the 
cardiovascular phenotype of the mother.
What Is Relevant?
•	The increased risk of future cardiovascular disease after preeclampsia 
does not exist for women with multi-fetal pregnancies and our results 
point to that these women might not need similar follow-up regarding 
future cardiovascular disease as women with preeclampsia in singleton 
pregnancies.
•	When allocating resources for follow-up, more effort can be directed to 
women with singelton pregnancies and preeclampsia.
Summary
Women with multi-fetal pregnancies have an increased risk of pre-
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